24
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Carbonic Anhydrase Activation Is Associated With Worsened Pathological Remodeling in Human Ischemic Diabetic Cardiomyopathy

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          Diabetes mellitus (DM) has multifactorial detrimental effects on myocardial tissue. Recently, carbonic anhydrases (CAs) have been shown to play a major role in diabetic microangiopathy but their role in the diabetic cardiomyopathy is still unknown.

          Methods and Results

          We obtained left ventricular samples from patients with DM type 2 (DM‐T2) and nondiabetic (NDM) patients with postinfarct heart failure who were undergoing surgical coronary revascularization. Myocardial levels of CA‐I and CA‐II were 6‐ and 11‐fold higher, respectively, in DM‐T2 versus NDM patients. Elevated CA‐I expression was mainly localized in the cardiac interstitium and endothelial cells. CA‐I induced by high glucose levels hampers endothelial cell permeability and determines endothelial cell apoptosis in vitro. Accordingly, capillary density was significantly lower in the DM‐T2 myocardial samples (mean±SE=2152±146 versus 4545±211/mm 2). On the other hand, CA‐II was mainly upregulated in cardiomyocytes. The latter was associated with sodium‐hydrogen exchanger‐1 hyperphosphorylation, exaggerated myocyte hypertrophy (cross‐sectional area 565±34 versus 412±27 μm 2), and apoptotic death (830±54 versus 470±34 per 10 6 myocytes) in DM‐T2 versus NDM patients. CA‐II is activated by high glucose levels and directly induces cardiomyocyte hypertrophy and death in vitro, which are prevented by sodium‐hydrogen exchanger‐1 inhibition. CA‐II was shown to be a direct target for repression by microRNA‐23b, which was downregulated in myocardial samples from DM‐T2 patients. MicroRNA‐23b is regulated by p38 mitogen‐activated protein kinase, and it modulates high‐glucose CA‐II–dependent effects on cardiomyocyte survival in vitro.

          Conclusions

          Myocardial CA activation is significantly elevated in human diabetic ischemic cardiomyopathy. These data may open new avenues for targeted treatment of diabetic heart failure.

          Related collections

          Most cited references37

          • Record: found
          • Abstract: found
          • Article: not found

          Revisiting the principles of microRNA target recognition and mode of action.

          MicroRNAs (miRNAs) are fundamental regulatory elements of animal and plant gene expression. Although rapid progress in our understanding of miRNA biogenesis has been achieved by experimentation, computational approaches have also been influential in determining the general principles that are thought to govern miRNA target recognition and mode of action. We discuss how these principles are being progressively challenged by genetic and biochemical studies. In addition, we discuss the role of target-site-specific endonucleolytic cleavage, which is the hallmark of experimental RNA interference and a mechanism that is used by plant miRNAs and a few animal miRNAs. Generally thought to be merely a degradation mechanism, we propose that this might also be a biogenesis mechanism for biologically functional, non-coding RNA fragments.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Myocardial cell death in human diabetes.

            The renin-angiotensin system is upregulated with diabetes, and this may contribute to the development of a dilated myopathy. Angiotensin II (Ang II) locally may lead to oxidative damage, activating cardiac cell death. Moreover, diabetes and hypertension could synergistically impair myocardial structure and function. Therefore, apoptosis and necrosis were measured in ventricular myocardial biopsies obtained from diabetic and diabetic-hypertensive patients. Accumulation of a marker of oxidative stress, nitrotyrosine, and Ang II labeling were evaluated quantitatively. The diabetic heart showed cardiac hypertrophy, cavitary dilation, and depressed ventricular performance. These alterations were more severe with diabetes and hypertension. Diabetes was characterized by an 85-fold, 61-fold, and 26-fold increase in apoptosis of myocytes, endothelial cells, and fibroblasts, respectively. Apoptosis in cardiac cells did not increase additionally with diabetes and hypertension. Diabetes increased necrosis by 4-fold in myocytes, 9-fold in endothelial cells, and 6-fold in fibroblasts. However, diabetes and hypertension increased necrosis by 7-fold in myocytes and 18-fold in endothelial cells. Similarly, Ang II labeling in myocytes and endothelial cells increased more with diabetes and hypertension than with diabetes alone. Nitrotyrosine localization in cardiac cells followed a comparable pattern. In spite of the difference in the number of nitrotyrosine-positive cells with diabetes and with diabetes and hypertension, apoptosis and necrosis of myocytes, endothelial cells, and fibroblasts were detected only in cells containing this modified amino acid. In conclusion, local increases in Ang II with diabetes and with diabetes and hypertension may enhance oxidative damage, activating cardiac cell apoptosis and necrosis.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Oxidative stress and redox signalling in cardiac hypertrophy and heart failure.

              Substantial evidence suggests the involvement of oxidative stress in the pathophysiology of congestive heart failure and its antecedent conditions such as cardiac hypertrophy and adverse remodelling after MI. Oxidative stress describes an imbalance between antioxidant defences and the production of reactive oxygen species (ROS), which at high levels cause cell damage but at lower levels induce subtle changes in intracellular signalling pathways (termed redox signalling). ROS are derived from many sources including mitochondria, xanthine oxidase, uncoupled nitric oxide synthases and NADPH oxidases. The latter enzymes are especially important in redox signalling, being implicated in the pathophysiology of hypertension and atherosclerosis, and activated by diverse pathologically relevant stimuli. We review the contribution of ROS to heart failure pathophysiology and discuss potential therapies that may specifically target detrimental redox signalling. Indeed, drugs such as ACE inhibitors and statins may act in part through such mechanisms. A better understanding of redox signalling mechanisms may enable the development of new targeted therapeutic strategies rather than the non-specific antioxidant approaches that have to date been disappointing in clinical trials.
                Bookmark

                Author and article information

                Journal
                J Am Heart Assoc
                J Am Heart Assoc
                ahaoa
                jah3
                Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
                Blackwell Publishing Ltd
                2047-9980
                April 2014
                25 April 2014
                : 3
                : 2
                : e000434
                Affiliations
                [1 ]Molecular and Cellular Cardiology, Department of Medical and Surgical Sciences, Magna Graecia University, Catanzaro, Italy (D.T., G.M.E., C.V., I.A., C.I., M.S., F.M., C.G., C.I.)
                [2 ]Stem Cell and Regenerative Biology Unit (BioStem), Faculty of Sciences, Liverpool John Moores University, Liverpool, UK (D.T., C.V., B.J.H.)
                [3 ]Centre of Human and Aerospace Physiological Sciences & Centre for Stem Cells and Regenerative Medicine, King's College London, School of Biomedical Sciences, Guys campus, London, SE1 1UL, UK (G.M.E., F.C.L.)
                [4 ]Department of Cardio‐Thoracic and Respiratory Sciences, Second University of Naples, Naples, Italy (M.T., G.N.)
                [5 ]Unit of Internal Medicine, Department of Internal and Experimental Medicine ‘Lanzara‐Magrassi’, Second University of Naples, Naples, Italy (N.L., T.S., R.T., D.C., F.C.S.)
                [6 ]Center of Cardiovascular Excellence, Second University of Naples, Naples, Italy (N.L., T.S., R.T., D.C., F.C.S.)
                [7 ]Laboratory of Proteomics and Mass Spectrometry, Department of Experimental and Clinical Medicine, Magna Graecia University, Catanzaro, Italy (G.C.)
                Author notes
                Correspondence to:Daniele Torella, MD, PhD, Molecular And Cellular Cardiology, Department of Medical and Surgical Sciences, Magna Graecia University, Campus S. Venuta, Viale Europa, Germaneto, 88100 Catanzaro, Italy. E‐mail: dtorella@ 123456unicz.it Ferdinando Carlo Sasso, MD, PhD, Division of Internal Medicine, Department of Internal and Experimental Medicine, Second University of Naples, 80121 Naples, Italy. E‐mail: ferdinando.sasso@ 123456unina2.it

                D. Torella, G.M. Ellison, and M. Torella contributed equally to this study.

                Article
                jah3435
                10.1161/JAHA.113.000434
                4187518
                24670789
                f6e28f35-82bd-4fc0-ac95-7f01a930af01
                © 2014 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley Blackwell.

                This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.

                History
                : 20 September 2013
                : 24 December 2013
                Categories
                Original Research
                Molecular Cardiology

                Cardiovascular Medicine
                apoptosis,carbonic anhydrase,diabetes mellitus,hypertrophy,microrna
                Cardiovascular Medicine
                apoptosis, carbonic anhydrase, diabetes mellitus, hypertrophy, microrna

                Comments

                Comment on this article